Britain's second-biggest drugmaker AstraZeneca has announced that the company's US patent over Pulmicort Respules asthma treatment has been invalidated by a court, allowing generic versions of the medicine that will hurt its profitability.
http://au.ibtimes.com/articles/452616/20130402/astrazeneca-patent-pulmicort-repsules-asthma.htm
http://au.ibtimes.com/articles/452616/20130402/astrazeneca-patent-pulmicort-repsules-asthma.htm
No comments:
Post a Comment